Related Experiment Video

Updated: Jun 10, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer

Vikash Reebye1, Charlotte L Bevan, Mahrokh Nohadani

  • 1Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London W12 0NN, United Kingdom.

Cellular Signalling
|August 7, 2010
PubMed

Insights

Researchers discovered a new interaction between CRKL and the androgen receptor (AR) that drives prostate cancer growth even without hormones. This finding offers insights into overcoming treatment resistance in advanced prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Androgen ablation therapy is a standard treatment for prostate cancer.
  • The mechanism of resistance to androgen ablation therapy is not fully understood.
  • The androgen receptor (AR) can remain active independently of hormone stimulation.

Purpose of the Study:

  • To investigate the mechanism of androgen receptor (AR) activity in hormone-independent prostate cancer.
  • To identify novel proteins interacting with the AR.
  • To explore potential therapeutic targets for advanced prostate cancer.

Main Methods:

  • Biochemical assays to confirm protein-protein interactions.
  • Genetic approaches, including siRNA knockdown, to assess functional relevance.
  • Localization studies in prostate cancer cells and patient biopsies.
  • Analysis of gene expression (PSA, human Kallikrein-2) and AR transactivation.

Main Results:

  • A novel cooperative interaction between CRKL and the AR was identified.
  • CRKL was found to be associated with the AR complex and localized in the nucleus.
  • CRKL's interaction with AR was functionally relevant, affecting gene regulation and AR transactivation.
  • CRKL expression, co-stimulated by growth factors, rescued AR activity in the presence of AR inhibitors, bypassing hormone dependency.

Conclusions:

  • CRKL is a key player in hormone-independent AR activity in prostate cancer.
  • The interaction between CRKL and AR provides a mechanism for bypassing hormone dependency.
  • Targeting the CRKL-AR interaction may offer a new therapeutic strategy for advanced prostate cancer.

More Related Videos

Serum and Plasma Copy Number Detection Using Real-time PCR09:21

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...